Kenneth Keymer Insider Profile
4 Followers
Kenneth Keymer, COO at Eterna Therapeutics, holds 98.10K shares in Eterna Therapeutics (Ticker: ERNA), holds 61.19K shares in Popeyes Louisiana Kitchen (Ticker: PLKI). Most recently, Kenneth Keymer Bought ― shares of Eterna Therapeutics on Jun 10, 2009 for an estimated value of $35.28K.
Kenneth Keymer's Trading History
| ERNAEterna Therapeutics | Jun 10, 2009 | COO | Informative Buy | 35.28K | $184.43K | |
| PLKIPopeyes Louisiana Kitchen | ― | ― | ― | $4.83M |
You May Also Like
Kenneth Keymer insider profile FAQ
What is the percentage of profitable transactions made by Kenneth Keymer?
The percentage of profitable transactions made by Kenneth Keymer is 0%.
What is the average return per transaction made by Kenneth Keymer?
The average return per transaction made by Kenneth Keymer is -15.00%.
What stocks does Kenneth Keymer hold?
Kenneth Keymer holds: ERNA, PLKI stocks.
What was Kenneth Keymer’s latest transaction?
Kenneth Keymer’s latest transaction was an Informative Buy of $35.28K.
What was Kenneth Keymer's most profitable transaction?
Kenneth Keymer’s most profitable transaction was an Informative Buy of ERNA stock on June 10, 2009. The return on the trade was 0.00%.
What is Kenneth Keymer's role in Eterna Therapeutics?
Kenneth Keymer's role in Eterna Therapeutics is COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
